معرفی
Antoine Gessain is a leading medical virologist and Head of Structure at the Oncogenic Virus Epidemiology and Pathophysiology (EPVO) unit at the Institut Pasteur in Paris. He received his MD and PhD from Parisian universities and has been instrumental in advancing research on retroviruses and oncogenic viruses since the unit's founding in 2001. He leads multiple research projects and collaborates with international institutions across Central Africa, French Guiana, and Peru.
His research interests include:
- Virology and molecular epidemiology of HTLV-1, HHV-8, and simian foamy viruses
- Zoonotic transmission of retroviruses from primates to humans
- Genetic diversity and global dissemination of oncogenic viruses
- Pathogenesis of HTLV-1-associated diseases such as myositis and neuromyelopathy
- Immunological responses to retroviral infections
His recent publications (2022–2025) reflect a strong focus on emerging viral threats, structural virology, and the molecular mechanisms of viral entry and immune neutralization. Notably, his team has contributed key insights into the structure of foamy virus envelope proteins, seroreactivity to ebolaviruses in Central Africa, and the epidemiology of HTLV-1 transmission in rural populations.
Dr. Gessain has received no explicitly mentioned scientific awards in the provided text. However, his role as principal investigator on multiple funded projects and his extensive publication record underscore his scientific impact.
He is actively involved in mentoring researchers and post-doctoral fellows, though specific PhD advisees are not listed. His work is supported by long-term collaborations with the Réseau International des Instituts Pasteur, CIRMF in Gabon, and Peruvian academic institutions. He also contributes to teaching at the Institut Pasteur, co-directing courses in systematic virology and infectious disease circulation.
His research unit operates at the intersection of basic virology, public health, and clinical applications, with strong links to hospital departments and animal care facilities for translational research.
